Suppr超能文献

伊维菌素群体药物治疗控制流行地区土壤传播性蠕虫感染的效果:系统评价和荟萃分析。

Effectiveness of ivermectin mass drug administration in the control of soil-transmitted helminth infections in endemic populations: a systematic review and meta-analysis.

机构信息

The Kirby Institute, University of New South Wales, Level 6, Wallace Wurth Building, Sydney, NSW, 2052, Australia.

出版信息

Infect Dis Poverty. 2024 Feb 18;13(1):16. doi: 10.1186/s40249-024-01185-5.

Abstract

BACKGROUND

Current soil-transmitted helminth (STH) control guidelines endorse the use of albendazole or mebendazole for school-based targeted preventive chemotherapy (PC), yet their reduced efficacy against Strongyloides stercoralis and Trichuris trichiura presents significant limitations. Emerging evidence indicates that community-wide PC [or mass drug administration (MDA)] using ivermectin, commonly used in other neglected tropical disease (NTD) control programs, may play an important role in controlling these parasites. We conducted a systematic review and meta-analysis to evaluate the effectiveness of ivermectin PC in reducing STH prevalence in endemic populations.

METHODS

We searched Pubmed, EMBASE, and Web of Science on February 14, 2023, for studies that investigated the effectiveness of ivermectin PC, either alone or in combination with other anthelmintic drugs, on STH infections, and provided a measure of STH prevalence before and after PC. We calculated pooled prevalence reductions for each STH using random-effects meta-analyses. Our protocol is available on PROSPERO (registration number CRD42023401219).

RESULTS

A total of 21 were eligible for the systematic review, of which 15 were eligible for meta-analysis. All studies delivered ivermectin through MDA. The pooled prevalence reduction of S. stercoralis following MDA with ivermectin alone was 84.49% (95% CI 54.96-94.66) across five studies and 81.37% (95% CI 61.62-90.96) across seven studies with or without albendazole. The prevalence reduction of T. trichiura was 49.93% (95% CI 18.23-69.34) across five studies with ivermectin alone, and 89.40% (95% CI 73.66-95.73) across three studies with the addition of albendazole. There was high heterogeneity for all syntheses (I > 65%).

CONCLUSIONS

This study underscores the key role of ivermectin-based MDA in addressing limitations in current global STH guidelines in terms of limited efficacy against S. stercoralis and T. trichiura. Based on these findings, revising international STH guidelines to include ivermectin is a promising option to progress the control and eventual elimination of STHs and other NTDs.

摘要

背景

目前的土壤传播性蠕虫(STH)控制指南支持使用阿苯达唑或甲苯达唑进行基于学校的目标预防性化疗(PC),但它们对旋毛虫和鞭虫的疗效降低存在重大局限性。新出现的证据表明,使用伊维菌素进行社区范围的 PC[或大规模药物管理(MDA)],在其他被忽视的热带病(NTD)控制计划中常用,可能在控制这些寄生虫方面发挥重要作用。我们进行了系统评价和荟萃分析,以评估伊维菌素 PC 降低流行地区 STH 患病率的效果。

方法

我们于 2023 年 2 月 14 日在 Pubmed、EMBASE 和 Web of Science 上搜索了研究伊维菌素 PC 对 STH 感染的有效性的研究,这些研究单独或与其他驱虫药物联合使用,并提供了 PC 前后 STH 患病率的衡量标准。我们使用随机效应荟萃分析计算了每种 STH 的汇总患病率降低。我们的方案可在 PROSPERO(注册号 CRD42023401219)上获得。

结果

共有 21 项研究符合系统评价的条件,其中 15 项符合荟萃分析的条件。所有研究均通过 MDA 提供伊维菌素。五项研究表明,单独使用伊维菌素进行 MDA 后,旋毛虫的总患病率降低了 84.49%(95%CI 54.96-94.66),七项研究中不论是否使用阿苯达唑,其患病率降低了 81.37%(95%CI 61.62-90.96)。单独使用伊维菌素的五项研究中,鞭虫的患病率降低了 49.93%(95%CI 18.23-69.34),三项研究中添加阿苯达唑后,其患病率降低了 89.40%(95%CI 73.66-95.73)。所有综合分析均存在高度异质性(I > 65%)。

结论

这项研究强调了基于伊维菌素的 MDA 在解决当前全球 STH 指南在旋毛虫和鞭虫疗效有限方面的关键作用。基于这些发现,修订国际 STH 指南以纳入伊维菌素是推进 STH 和其他 NTD 控制和最终消除的有希望的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb61/10874526/c5037f6d0100/40249_2024_1185_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验